Uncovering Microbiome-Derived Therapeutic Targets to Treat Alzheimer’s Disease
Time: 11:30 am
day: Track A - Day 2
- Investigating Alzheimer’s disease in the context of the microbiome: what do biopharma need to know?
- Analyzing how microbial DNAs involvement in Alzheimer’s disease can be exploited as a treatment strategy against it
- Revealing how DNA of some species triggers protein misfolding and learning how this influences Alzheimer’s development and progression